Search for: "Actavis" Results 681 - 700 of 1,010
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2013, 11:03 am by David Lat
Actavis Inc., Gera Vaz, Jon Leibowitz, Lateral Hiring, Lateral Moves, Laterals, Linda C. [read post]
18 Jun 2013, 10:24 am by Michael Carrier
In this case, the Supreme Court considered an arrangement by which brand firm Solvay paid generics Watson (now Actavis) and Paddock roughly $30 to $40 million to delay entering the market with generic versions of testosterone gel. [read post]
18 Jun 2013, 8:18 am by Matthew Lanahan
Actavis; the firm’s Tejinder Singh was among the counsel on an amicus brief filed by international human rights advocates in support of the respondents in Hollingsworth v. [read post]
18 Jun 2013, 7:15 am by Matt Kaiser
Actavis Inc., Generic Drugs, Intellectual Property, Matt Kaiser, Monopoly, Patents, Pharmaceuticals, SCOTUS, Settlements, Supreme Court     [read post]
18 Jun 2013, 6:08 am by Staci Zaretsky
Actavis Inc., Grades, Guantanamo Bay, Hispanic National Bar Association, Hispanics, Immigration, Jon Leibowitz, Lateral Moves, Law Firm Mergers, Law School Applications, Law Schools, Leaks, Legal Ethics, Minority Issues, Morning Docket, National Security Agency, NSA, SCOTUS, Skadden, Skadden Arps, Skadden Arps Slate Meagher & Flom LLP, Supreme Court, Ted Cruz     [read post]
17 Jun 2013, 1:21 pm by Lyle Denniston
Actavis (docket 12-416) was based far more on antitrust than patent law, and was at least a warning that settling lawsuits — at least in the drug industry — is a practice not necessarily free from risk. [read post]
17 Jun 2013, 1:03 pm by David Kemp
Actavis, Inc., United States Supreme Court (6/17/13)Antitrust & Trade Regulation, Drugs & BiotechThe Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Act), 21 U.S.C. 355(j)(2)(A)(vii)(IV) established procedures for identifying and resolving patent disputes between brand-name and generic drug manufacturers. [read post]
17 Jun 2013, 11:38 am by Will Baude
Actavis: That's a lot of citations to legal scholarship in the majority opinion. [read post]
17 Jun 2013, 7:44 am by Kali Borkoski
This case is an antitrust challenge to an increasingly common practice in the pharmaceutical industry. [read post]
16 Jun 2013, 3:49 pm by Kedar Bhatia
Actavis 12-416Disclosure: Goldstein & Russell, P.C., whose attorneys work for or contribute to this blog in various capacities, also represented Louisiana Wholesale Drug Company et al. as an amicus in support of the petitioner in this case.Issue: Whether reverse-payment agreements are per se lawful unless the underlying patent litigation was a sham or the patent was obtained by fraud (as the court below held), or instead are presumptively anticompetitive and unlawful (as the Third… [read post]
10 Jun 2013, 11:38 am by Kedar Bhatia
Actavis 12-416Disclosure: Goldstein & Russell, P.C., whose attorneys work for or contribute to this blog in various capacities, also represented Louisiana Wholesale Drug Company et al. as an amicus in support of the petitioner in this case.Issue: Whether reverse-payment agreements are per se lawful unless the underlying patent litigation was a sham or the patent was obtained by fraud (as the court below held), or instead are presumptively anticompetitive and unlawful (as the Third… [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
28 Apr 2013, 8:40 am
In Part Two of this series of Katposts, we looked at the diffusion of patent assertion entities in England and Wales, where data show that only 6% of patent cases involve a PAE (in the US, instead, PAEs filed 56% of patent lawsuits in 2012 - see Part One). [read post]